首页> 外国专利> Determining Cancer-Linked Genes and Therapeutic Targets Using Molecular Cytogenetic Methods

Determining Cancer-Linked Genes and Therapeutic Targets Using Molecular Cytogenetic Methods

机译:使用分子细胞遗传学方法确定癌症相关基因和治疗靶标

摘要

Methods for identifying antineoplastic agents by using their ability to modify expression of specific genes or the biological activity of polypeptides encoded by such genes, wherein said genes are located in specific chromosomal regions, called amplicons, or regions of interest, and the presence of such amplified regions within a cancerous cell, are disclosed. Also described are methods for diagnosing cancerous, or potentially cancerous, conditions using these methods. Also encompassed are methods involving determining the modulated expression of the genes in these regions of interest (ROIs), or amplicons, as pharmacodynamic/pharmacogenetic/surrogate markers and/or for patient profiling prior to accrual for clinical trials/treatments based on the identification of these genes as validated gene/drug targets in various cancer tissue types.
机译:通过利用抗肿瘤剂修饰特定基因的表达或由该基因编码的多肽的生物学活性来鉴定抗肿瘤剂的方法,其中所述基因位于特定的染色体区域(称为扩增子或目的区域)中,并且存在此类扩增子公开了癌细胞内的区域。还描述了使用这些方法诊断癌性或潜在癌性的方法。还包括涉及以下方法:确定在这些目标区域(ROIs)或扩增子中的基因的调制表达,作为药效学/药理遗传学/替代标记和/或在基于临床试验或治疗的临床累积进行治疗前对患者进行分析,这些基因作为各种癌症组织类型中经过验证的基因/药物靶标。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号